FRACASSI, Elena
 Distribuzione geografica
Continente #
EU - Europa 3.531
NA - Nord America 3.428
AS - Asia 2.477
SA - Sud America 393
AF - Africa 80
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.918
Nazione #
US - Stati Uniti d'America 3.360
RU - Federazione Russa 1.299
SG - Singapore 1.036
GB - Regno Unito 891
CN - Cina 675
IT - Italia 332
BR - Brasile 320
SE - Svezia 214
VN - Vietnam 207
HK - Hong Kong 191
DE - Germania 184
FR - Francia 152
FI - Finlandia 147
IE - Irlanda 145
KR - Corea 74
TR - Turchia 64
JP - Giappone 51
IN - India 49
UA - Ucraina 42
CA - Canada 34
AR - Argentina 26
BD - Bangladesh 26
IQ - Iraq 24
NL - Olanda 20
AT - Austria 19
MX - Messico 19
BE - Belgio 17
ZA - Sudafrica 17
ES - Italia 16
EC - Ecuador 15
NG - Nigeria 14
NP - Nepal 14
ID - Indonesia 12
PK - Pakistan 11
PL - Polonia 11
BJ - Benin 8
CO - Colombia 8
PE - Perù 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MA - Marocco 7
SA - Arabia Saudita 7
AU - Australia 6
IR - Iran 6
LT - Lituania 6
TG - Togo 6
CH - Svizzera 5
GR - Grecia 5
KE - Kenya 5
PY - Paraguay 5
VE - Venezuela 5
JM - Giamaica 4
LB - Libano 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
RO - Romania 3
SI - Slovenia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BW - Botswana 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
PH - Filippine 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BT - Bhutan 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NZ - Nuova Zelanda 1
PA - Panama 1
PF - Polinesia Francese 1
Totale 9.913
Città #
Southend 767
Singapore 577
Moscow 455
Ashburn 391
San Jose 346
Chandler 329
Dallas 316
Jacksonville 287
Hong Kong 187
Ann Arbor 174
Dublin 145
Woodbridge 132
Verona 125
Beijing 124
The Dalles 108
Houston 101
New York 82
Los Angeles 74
Ho Chi Minh City 73
Lawrence 54
Princeton 54
Wilmington 53
Jinan 49
Hanoi 48
Tokyo 47
Munich 39
Milan 38
Nanjing 37
Shenyang 36
São Paulo 34
Helsinki 33
Redmond 30
Redondo Beach 24
Buffalo 23
Turku 23
London 20
Zhengzhou 20
Columbus 19
Santa Clara 19
Tianjin 19
Ningbo 18
Orem 18
Haikou 17
Hebei 17
Brussels 16
Changsha 16
Boardman 15
Brooklyn 15
Sindelfingen 15
Abuja 14
Amsterdam 14
Atlanta 14
Falkenstein 14
Fuzhou 14
Taizhou 14
Jiaxing 13
Montreal 13
Taiyuan 13
Boston 12
Council Bluffs 12
Johannesburg 12
Redwood City 12
Rio de Janeiro 12
Baghdad 11
Chicago 11
Kathmandu 11
Nanchang 11
San Francisco 11
Chennai 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Phoenix 10
Seattle 10
Washington 10
Düsseldorf 9
Hangzhou 9
Lancaster 9
Orani 9
Poplar 9
Vienna 9
Ankara 8
Belo Horizonte 8
Cotonou 8
Jakarta 8
Stockholm 8
Manchester 7
Mexico City 7
Norwalk 7
Sanayi 7
Warsaw 7
Brasília 6
Cagliari 6
Charlotte 6
Detroit 6
Dongguan 6
Hyderabad 6
Izmir 6
Totale 6.158
Nome #
Artrite Reumatoide e Metabolismo Minerale 268
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 241
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 233
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 210
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 206
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 197
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 186
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 175
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 169
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 166
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 165
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 165
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 163
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 163
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 161
Artropatie degenerative 159
Sclerostin and DKK1 in primary hyperparathyroidism. 159
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 157
Prevalence of osteoporosis in patients affected by mastocytosis 156
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 152
Development and First Validation of a Disease Activity Score for Gout 152
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 151
Osteopetrosi 149
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 149
Invecchiamento dell'apparato scheletrico 145
Focal bone involvement in inflammatory arthritis: the role of IL17 144
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 143
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 142
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 141
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 138
Vitamina D e artrite reumatoide 137
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 136
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 135
Changes in bone turnover markers and bone modulators during abatacept treatment 134
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 134
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 131
Osteoporosi 130
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 129
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 128
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 125
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 125
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 124
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 124
Vitamin D and rheumatic diseases. 121
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 120
Neridronic acid for the treatment of bone metabolic diseases 119
Osteoporosis Treatment: When to Discontinue and When to Re-start 117
Vitamin D and fractures: a systematic review 116
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 113
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 112
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 110
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 107
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 106
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 103
Risk factors for hip fracture in elderly persons 98
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 92
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 91
Risk factors for hip fracture in elderly persons 91
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 90
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 90
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 89
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 86
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 86
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 86
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 85
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 85
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 84
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 27
Totale 10.033
Categoria #
all - tutte 32.537
article - articoli 29.696
book - libri 0
conference - conferenze 646
curatela - curatele 0
other - altro 417
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.778
Totale 65.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 5 47 27
2021/2022459 23 147 12 13 27 19 7 23 44 7 38 99
2022/2023998 70 107 84 177 54 244 11 68 122 17 33 11
2023/2024539 23 30 43 53 70 94 23 65 7 14 75 42
2024/20251.499 71 79 73 223 79 60 90 66 223 133 129 273
2025/20264.293 306 256 321 828 1.104 316 448 237 283 194 0 0
Totale 10.033